LifeMD Inc reports results for the quarter ended September 30 - Earnings Summary

• LifeMD Inc reported a quarterly adjusted loss of 11 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -7 cents. The mean expectation of eight analysts for the quarter was for a loss of 14 cents per share. Wall Street expected results to range from -26 cents to -7 cents per share.

• Revenue fell 25.8% to $44.63 million from a year ago; analysts expected $48.89 million.

• LifeMD Inc's reported EPS for the quarter was a loss of 11 cents​.

• The company reported a quarterly loss of $5.25 million.

• LifeMD Inc shares had fallen by 38.6% this quarter and lost 47.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for LifeMD Inc is $7.50, about 77.9% above its last closing price of $1.66

This summary was machine generated from LSEG data November 12 at 10:55 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)